DMD Large equally mixed donor pool

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by El-Kadi, A. O. S.
Right arrow Articles by du Souich, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by El-Kadi, A. O. S.
Right arrow Articles by du Souich, P.

Vol. 28, Issue 9, 1112-1120, September 2000

Role of Reactive Oxygen Intermediates in the Decrease of Hepatic Cytochrome P450 Activity by Serum of Humans and Rabbits with an Acute Inflammatory Reaction

Ayman O. S. El-Kadi, Anne-Marie Bleau, Isabelle Dumont, Hélène Maurice, and Patrick du Souich

Département de Pharmacologie, Faculté de Médecine, Université de Montréal Montréal, Québec, Canada

Serum of rabbits with a turpentine-induced acute inflammatory reaction (RSINFLA) and serum of humans with a viral infection (HSINF) were previously shown to diminish hepatic cytochrome P450 (P450) content and activity. To document the role of reactive oxygen intermediates in the serum-mediated decrease in P450 content and activity, hepatocytes of rabbits with an acute inflammatory reaction (HINFLA) were incubated with RSINFLA and HSINF for 4 h, and total P450 content (spectrally measurable P450), P450 activity (assessed by estimating the formation of theophylline metabolites), and amount of CYP1A1, CYP1A2, and CYP3A6 proteins were measured. RSINFLA or HSINF decreased P450 content and activity without affecting the amount of CYP1A1 and -1A2 HINFLA. Exposure of HCONT or HINFLA to hydrogen peroxide (0.01-1.0 mM) and sodium nitroprusside (0.01-1.0 mM) produced a dose-dependent decrease in P450 content and in the formation of theophylline metabolites without modifying the amount of CYP1A1 and CYP1A2, whereas lipid peroxidation increased. Incubation of L-NAME (0.05-1.0 mM), dimethylthiourea (6.25-50 mM), or N-acetylcysteine (0.01-1.0 mM) with HINFLA partially prevented the decrease in P450 content and activity and the increased lipid peroxidation induced by RSINFLA and HSINF. On the other hand, 3-amino-1,2,4-triazole (10-100 mM) or diethyldithiocarbamate (1.0-10 mM) potentiated RSINFLA- and HSINF-mediated decreases in P450 content and activity and the increase in lipid peroxidation, without affecting the amount of CYP1A1 or -1A2; DL-buthionine-(S,R)-sulfoximine (2.5-25 mM) potentiated only the inhibition of 1,3-dimethyluric acid formation. It is concluded that reactive oxygen intermediates are implicated in the decrease of HINFLA P450 content and activity induced by 4 h of exposure to RSINFLA or HSINF.


Copyright © 2000 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
Drug Metab. Dispos.Home page
O. Kourylko, C. Fradette, M. Arcand, and P. du Souich
MODULATION OF CYP1A2 AND CYP3A6 CATALYTIC ACTIVITIES BY SERUM FROM RABBITS WITH A TURPENTINE-INDUCED INFLAMMATORY REACTION AND INTERLEUKIN 6
Drug Metab. Dispos., January 1, 2006; 34(1): 27 - 35.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
H. Miura, J. J. Bosnjak, G. Ning, T. Saito, M. Miura, and D. D. Gutterman
Role for Hydrogen Peroxide in Flow-Induced Dilation of Human Coronary Arterioles
Circ. Res., February 7, 2003; 92 (2): e31 - e40.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
A.-M. Bleau, C. Fradette, A. O. S. El-Kadi, M.-C. Cote, and P. du Souich
Cytochrome P450 Down-Regulation by Serum from Humans with a Viral Infection and from Rabbits with an Inflammatory Reaction
Drug Metab. Dispos., July 1, 2001; 29(7): 1007 - 1012.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
S. De Flora, A. Izzotti, F. D'Agostini, and R. M. Balansky
Mechanisms of N-acetylcysteine in the prevention of DNA damage and cancer, with special reference to smoking-related end-points
Carcinogenesis, July 1, 2001; 22(7): 999 - 1013.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
E. T. Morgan
Regulation of Cytochrome P450 by Inflammatory Mediators: Why and How?
Drug Metab. Dispos., March 1, 2001; 29(3): 207 - 212.
[Abstract] [Full Text]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2000 by the American Society for Pharmacology and Experimental Therapeutics.